POT1 and cancer: In addition, five of the participants with the POT1 mutations had different types of blood-related cancers, and 8 of 12 (67%) people analyzed also had an age-related blood condition called clonal hematopoiesis of indeterminate potential (CHIP), which has been linked to an increased risk for blood and other cancers [133].